Key facts
- This page summarizes Thierry Pieton's Form 4 filing for Medtronic plc (MDT).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 05 Mar 2025, 17:22.
Thierry Pieton - 03 Mar 2025 Form 4 Insider Report for Medtronic plc (MDT)
- Reporting relationship
- EVP & Chief Financial Officer
- Issuer ticker
- MDT
- Reported as of
- 03 Mar 2025
- Net transaction value
- +$2,900,102
- SEC form
- 4
- Accepted by SEC
- 05 Mar 2025, 17:22:08 UTC
- Next SEC filing
- 30 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas L. Osteraas, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Thierry Pieton filed Form 4 for Medtronic plc (MDT) on 05 Mar 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$2,900,102.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
This filing has been restated.
Open the amended filing.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDT
transaction
Ordinary Shares
Award
- Transaction value
- $400,021
- Shares
- +4,242
- Change %
- Price
- $94.30
- Shares after
- 4,242
- Date
- 03 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
MDT
transaction
Ordinary Shares
Award
- Transaction value
- $2,500,082
- Shares
- +26,512
- Change %
- +625%
- Price
- $94.30
- Shares after
- 30,754
- Date
- 03 Mar 2025
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MDT
transaction
Derivative
Performance Share Unit
Award
- Transaction value
- $0
- Shares
- +10,605
- Change %
- Price
- $0.000000
- Shares after
- 10,605
- Date
- 03 Mar 2025
- Ownership
- Direct
- Underlying class
- Performance Share Units
- Underlying amount
- 10,605
- Exercise price
- Footnotes
- F3, F4, F5
MDT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +29,574
- Change %
- Price
- $0.000000
- Shares after
- 29,574
- Date
- 03 Mar 2025
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 29,574
- Exercise price
- $94.30
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
Footnote F2
Represents restricted stock units that vest in three annual installments beginning one year from the date of grant.
Footnote F3
Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
Footnote F4
Vests on April 30, 2027.
Footnote F5
The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 10,605 shares will be issued. If maximum performance metrics are achieved, 21,210 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
Footnote F6
The options are exercisable in four annual installments beginning one year from the date of grant.